Dentsply Int'l (XRAY) Tops Q3 EPS by 2c

Dentsply Int'l (NASDAQ: XRAY) reported Q3 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $708 million versus the consensus estimate of $725.83 million.

For earnings history and earnings-related data on Dentsply Int'l (XRAY) click here.

You May Also Be Interested In

• AEVEX Corp. (AVEX) Reports Q2 EPS of $0.01; offers guidance
• Aviragen Therapeutics (AVIR) Tops Q2 EPS by 15c
• Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance